Brazilian pharma and consumer health manufacturer scaling production and SAP infrastructure
Farmax is a pharmaceutical and consumer health conglomerate operating in Brazil with 1,000+ employees across manufacturing, OPS, and support functions. The company is mid-stage in a major SAP S/4HANA rollout while managing tight operational constraints—pain points cluster heavily around production stability (line stoppages, rework, deviations) and regulatory compliance. Junior-heavy hiring velocity (9 of 15 recent roles) alongside manufacturing and ops focus suggests operational scaling rather than product innovation.
Farmax operates as a multi-brand health and beauty group spanning pharmaceuticals, cosmetics, supplements, and wellness products. The portfolio includes Farmax (flagship), Sunless, Sanavita (acquired 2023), and Negra Rosa (acquired 2022). Based in Divinópolis, MG, the company manufactures and distributes across Brazil. Founded in 1980 and backed by Vinci Partners (VCP III fund since 2021), Farmax employs 1,001–5,000 people. The operational footprint emphasizes manufacturing capacity, regulatory compliance, and supply-chain execution across a diversified product range.
SAP S/4HANA, SAP ECC, SAP SD, ABAP, Salesforce, Jira, Power BI, and Microsoft Office suite. Currently rolling out S/4HANA and evolving SAP SD modules while integrating legacy systems.
Production stability (line stoppages, rework, deviations), regulatory compliance, risk identification and monitoring, reducing non-conformities, and integrating SAP SD with legacy systems. Service level improvement is also a priority.
Other companies in the same industry, closest in size